Status:
COMPLETED
Interpretation of Transnasal Esophagoscopy Findings
Lead Sponsor:
Vanderbilt University
Conditions:
Larynx Disease
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine the prevalence of esophageal pathology in patients with voice disorders. In addition, , the intra- and interdisciplinary variability regarding the identificat...
Detailed Description
Throat symptoms are common complaints for many patients. Some symptoms are thought to be attributable to laryngopharyngeal reflux (i.e. the reflux of stomach acid to the level of the larynx). It is un...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Study participants include persons 18 years and older
- Patients presenting to the Vanderbilt Voice Center and complaining of throat symptoms. These include hoarseness, throat clearing/pain/burning, heartburn, globus sensation, and acidic/sour taste.
- New and return patients will be included.
- Exclusion criteria:
- Participants who are unwilling to undergo the study
- Patients who have had prior esophagoscopy
- Those who do not sign the consent
- Pregnant women.
Exclusion
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2008
Estimated Enrollment :
98 Patients enrolled
Trial Details
Trial ID
NCT00372918
Start Date
September 1 2006
End Date
April 1 2008
Last Update
June 5 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt ENT Clinic
Nashville, Tennessee, United States, 37232-5280